MLTX Q4 2025 Earnings — MoonLake Immunotherapeutics Revenue & Financial Results | Market Cap Arena

MLTXMoonLake Immunotherapeutics

$1B

Q4 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$751,000

Operating Income

-$65M

Net Income

-$62M

EPS (Diluted)

$-0.93

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$59M

Free Cash Flow

-$59M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$424M

Total Liabilities

$120M

Stockholders' Equity

$304M

Cash & Equivalents

$335M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$751,000	$0	—
Operating Income	-$65M	-$50M	-31.5%
Net Income	-$62M	-$46M	-36.9%